关注
Anastasia Madenidou
Anastasia Madenidou
在 manchester.ac.uk 的电子邮件经过验证
标题
引用次数
引用次数
年份
Comparative benefits and harms of basal insulin analogues for type 2 diabetes: a systematic review and network meta-analysis
AV Madenidou, P Paschos, T Karagiannis, A Katsoula, E Athanasiadou, ...
Annals of internal medicine 169 (3), 165-174, 2018
632018
Association between response rates and survival outcomes in patients with newly diagnosed multiple myeloma. A systematic review and meta‐regression analysis
M Mainou, AV Madenidou, A Liakos, P Paschos, T Karagiannis, E Bekiari, ...
European Journal of Haematology 98 (6), 563-568, 2017
142017
Switching patients with inflammatory arthritis from Etanercept (Enbrel®) to the biosimilar drug, SB4 (Benepali®): a single-centre retrospective observational study in the UK …
AV Madenidou, A Jeffries, S Varughese, S Jones, H Sari-Kouzel, ...
Mediterranean Journal of Rheumatology 30 (2), 69-75, 2019
122019
Cardiovascular disease in the systemic vasculitides
S Soulaidopoulos, AV Madenidou, D Daoussis, K Melissaropoulos, ...
Current Vascular Pharmacology 18 (5), 463-472, 2020
112020
The role of whole-body MRI in musculoskeletal inflammation detection and treatment response evaluation in inflammatory arthritis across age: A systematic review
V Choida, AV Madenidou, D Sen, MA Hall-Craggs, C Ciurtin
Seminars in Arthritis and Rheumatism 52, 151953, 2022
82022
Real-life experience of tocilizumab use in COVID-19 patients
AV Madenidou, M Bukhari
Rheumatology 59 (8), 2163-2166, 2020
62020
Adalimumab or etanercept as first line biologic therapy in enthesitis related arthritis (ERA)-a drug-survival single centre study spanning 10 years
MRA Shipa, N Heyer, R Mansoor, CT Deakin, AV Madenidou, A Bouraioui, ...
Seminars in Arthritis and Rheumatism 55, 152038, 2022
52022
Switching patients with arthritis from etanercept (enbrel) to the biosimilar drug, benepali: a single-center retrospective observational study
AV Madenidou
2018 ACR/ARHP Annual Meeting, 2018
52018
Cardiovascular Disease and Cardiac Imaging in Inflammatory Arthritis
AV Madenidou, S Mavrogeni, E Nikiphorou
Life 13 (4), 909, 2023
12023
Thank you to the reviewers of Rheumatology Advances in Practice 2022
AL Tan
Rheumatology Advances in Practice 7 (1), 2023
12023
AB1084 A SYSTEMATIC REVIEW OF THE ABILITY OF WHOLE BODY MRI TO ASSESS DISEASE ACTIVITY AND TREATMENT RESPONSE IN INFLAMMATORY ARTHRITIS
V Choida, AV Madenidou, D Sen, M Hall-Craggs, C Ciurtin
Annals of the Rheumatic Diseases 79 (Suppl 1), 1831-1831, 2020
12020
Basal insulin analogues for type 2 diabetes: systematic review and network meta-analysis
A Tsapas, AV Madenidou, T Karagiannis, P Paschos, E Athanasiadou, ...
52nd EASD Annual Meeting, Munich, Germany: Diabetologia 59 (Suppl 1), S403, 2016
12016
Telerheumatology during the COVID-19 pandemic: Impact on clinical practice, education, and research
SA Yeoh, AV Madenidou
Indian Journal of Rheumatology 17 (7), 394, 2022
2022
Smartphone images of digital ulcers provide a clear picture of disease progression for the first rheumatology visit
AV Madenidou, G Dinsdale, M Samaranayaka, L Muir, WG Dixon, ...
Rheumatology, 2022
2022
Ultrasound in rheumatology
DR Ludwig, AV Madenidou
Medicine 50 (2), 104-108, 2022
2022
Monoclonal Antibodies in Rheumatology
A Madenidou, C Ciurtin
Euromed Communications, 2020
2020
The Relationship Between Body Fat Percentage and Bone Mineral Density in Rheumatoid Arthritis Patients
AV Madenidou, M Bukhari
ARTHRITIS & RHEUMATOLOGY 72, 2020
2020
The management of rheumatoid arthritis
S Dyball, AV Madenidou, C Saleh, Y Tan, F Wood, L Ottewell
Morecambe Bay Medical Journal 8 (6), 160-161, 2020
2020
P28 Marfan syndrome? Think again!
AV Madenidou, V Choida, V Reddy, H Kazkaz
Rheumatology 59 (Supplement_2), keaa111. 027, 2020
2020
P18 Presence of rheumatoid factor was associated with a decreased risk of lupus nephritis in patients with juvenile systemic lupus erythematosus
Y Mahfouz, AV Madenidou, O Chang, F El-Sharnouby, C Foley, C Ciurtin
Lupus Science & Medicine 7 (Suppl 1), 2020
2020
系统目前无法执行此操作,请稍后再试。
文章 1–20